These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

124 related items for PubMed ID: 6663299

  • 21.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 22.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 23. Pharmacological modification of experimental tardive dyskinesia.
    Bárány S, Gunne LM.
    Acta Pharmacol Toxicol (Copenh); 1979 Aug; 45(2):107-11. PubMed ID: 115227
    [Abstract] [Full Text] [Related]

  • 24.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 25. Effects of dopamine agonists, catecholamine depletors, and cholinergic and GABAergic drugs on acute dyskinesias in squirrel monkeys.
    Neale R, Gerhardt S, Liebman JM.
    Psychopharmacology (Berl); 1984 Aug; 82(1-2):20-6. PubMed ID: 6320248
    [Abstract] [Full Text] [Related]

  • 26.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28. Deficient striatal adaptation in aminergic and glutamatergic neurotransmission is associated with tardive dyskinesia in non-human primates exposed to antipsychotic drugs.
    Lévesque C, Hernandez G, Mahmoudi S, Calon F, Gasparini F, Gomez-Mancilla B, Blanchet PJ, Lévesque D.
    Neuroscience; 2017 Oct 11; 361():43-57. PubMed ID: 28790021
    [Abstract] [Full Text] [Related]

  • 29. Dopaminergic agents including 3-PPP and its enantiomers on medial septal self-stimulation.
    Gower AJ, Broekkamp CL.
    Pharmacol Biochem Behav; 1985 Feb 11; 22(2):309-15. PubMed ID: 3872462
    [Abstract] [Full Text] [Related]

  • 30. A behavioural study of the changes in the central nervous system of mice after subchronic treatment with the selective dopamine autoreceptor agonist 3-PPP (dl-3-[3-hydroxyphenyl]-N-n-propylpiperidine).
    Jackson D, Carlsson A, Hjorth S, Lindberg P.
    J Neural Transm; 1982 Feb 11; 53(4):233-45. PubMed ID: 6286867
    [Abstract] [Full Text] [Related]

  • 31. Effect of 5-HT1A and 5-HT2A/2C receptor modulation on neuroleptic-induced vacuous chewing movements.
    Naidu PS, Kulkarni SK.
    Eur J Pharmacol; 2001 Sep 28; 428(1):81-6. PubMed ID: 11779040
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Neuroleptic-induced acute dyskinesias in rhesus monkeys.
    Porsolt RD, Jalfre M.
    Psychopharmacology (Berl); 1981 Sep 28; 75(1):16-21. PubMed ID: 6117919
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Pentadecapeptide BPC 157 attenuates disturbances induced by neuroleptics: the effect on catalepsy and gastric ulcers in mice and rats.
    Jelovac N, Sikiric P, Rucman R, Petek M, Marovic A, Perovic D, Seiwerth S, Mise S, Turkovic B, Dodig G, Miklic P, Buljat G, Prkacin I.
    Eur J Pharmacol; 1999 Aug 20; 379(1):19-31. PubMed ID: 10499368
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38. Dopamine receptor agonistic and antagonistic effects of 3-PPP enantiomers.
    Arnt J, Bøgesø KP, Christensen AV, Hyttel J, Larsen JJ, Svendsen O.
    Psychopharmacology (Berl); 1983 Aug 20; 81(3):199-207. PubMed ID: 6139838
    [Abstract] [Full Text] [Related]

  • 39. Experimental tardive dyskinesia.
    Gunne LM, Häggström JE.
    J Clin Psychiatry; 1985 Apr 20; 46(4 Pt 2):48-50. PubMed ID: 2858481
    [Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.